Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 520-528

  Hambrock, Thomas ^a   Somford, Diederik M ^a   Hoeks, Caroline ^a   Bouwense, Stefan A W ^a   Huisman, Henkjan ^a   Yakar, Derya ^a   van Oort, Inge M ^a   Witjes, J Alfred ^a   Fütterer, Jurgen J ^a   Barentsz, Jelle O ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

biopsy; magnetic resonance imaging; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE TUMOR; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR VOLUME; URINARY TRACT INFECTION;

AGED; BIOPSY, NEEDLE; FALSE NEGATIVE REACTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 73749085789     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.10.022     Document Type: Article

References (30)

1. Umbehr M., Bachmann L.M., Held U., et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol 55 (2008) 591
2. Heijmink S.W., Futterer J.J., Hambrock T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244 (2007) 184
3. Tanimoto A., Nakashima J., Kohno H., et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25 (2007) 146
4. Halpern E.J., and Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 174 (2000) 623
5. Mitterberger M., Pinggera G.M., Horninger W., et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 178 (2007) 464
6. Pelzer A., Bektic J., Berger A.P., et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173 (2005) 1926
7. Huisman H.J., Engelbrecht M.R., and Barentsz J.O. Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 13 (2001) 607
8. Akin O., Sala E., Moskowitz C.S., et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239 (2006) 784
9. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449
10. Hambrock T., Futterer J.J., Huisman H.J., et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 43 (2008) 686
11. Augustin H., Hammerer P.G., Graefen M., et al. Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction. Eur Urol 43 (2003) 455
12. Bastian P.J., Mangold L.A., Epstein J.I., et al. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 101 (2004) 2001
13. Nakanishi H., Wang X., Ochiai A., et al. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Cancer 110 (2007) 2441
14. Ochiai A., Troncoso P., and Babaian R.J. The relationship between serum prostate specific antigen level and tumor volume persists in the current era. J Urol 177 (2007) 903
15. Xu S., Kruecker J., Turkbey B., et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 13 (2008) 255
16. Mian B.M., Naya Y., Okihara K., et al. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 60 (2002) 836
17. Philip J., Hanchanale V., Foster C.S., et al. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. BJU Int 98 (2006) 559
18. Roehl K.A., Antenor J.A., and Catalona W.J. Serial biopsy results in prostate cancer screening study. J Urol 167 (2002) 2435
19. Eskicorapci S.Y., Guliyev F., Akdogan B., et al. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol 173 (2005) 1536
20. Campos-Fernandes J.L., Bastien L., Nicolaiew N., et al. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Eur Urol 55 (2008) 600
21. Pepe P., and Aragona F. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 70 (2007) 1131
22. Stav K., Leibovici D., Sandbank J., et al. Saturation prostate biopsy in high risk patients after multiple previous negative biopsies. Urology 71 (2008) 399
23. Walz J., Graefen M., Chun F.K., et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 50 (2006) 498
24. Taylor III J.A., Gancarczyk K.J., Fant G.V., et al. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer. Urology 60 (2002) 841
25. Dugan J.A., Bostwick D.G., Myers R.P., et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 275 (1996) 288
26. Miyake H., Sakai I., Harada K., et al. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Int J Urol 12 (2005) 270
27. Sakai I., Harada K., Hara I., et al. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 96 (2005) 528
28. Anastasiadis A.G., Lichy M.P., Nagele U., et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with increased or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50 (2006) 738
29. Beyersdorff D., Winkel A., Hamm B., et al. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234 (2005) 576
30. Engelhard K., Hollenbach H.P., Kiefer B., et al. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 16 (2006) 1237